2006 - UZ Leuven

pelvic lymph node status were not withheld as independent factors inpredicting CCS, BPFS and CPFS. Pathological stage was a significantindependent predictor in CSS. There were no significant differencesbetween pT2 and pT3a-b in CSS, BPFS and CPFS.Conclusions: RP is a valuable treatment option in unilateral cT3aprostate cancer, yielding very high 10-year overall and cancer specificoutcomes. More than half of the patients might need adjuvant orsalvage treatment.JONIAU S., ALBERSEN M., VAN POPPEL H.: Combined reporting offunctional and oncological results following open radicalprostatectomy using the ‘Salomon-score’. J. Sex Med., 2006: 64.Objective: Since functional outcome becomes more important to(increasingly younger) patients, we think combined oncologic andfunctional reporting is valuable in the comparison of outcome of RRPbetween various centres. In 2003, Salomon et al. proposed a scoringsystem to jointly report cancer control and functional results followingRRP. We aimed to evaluate the use of this scoring system in our ownexperience.Methods: Between January 2001 and November 2004, 272 patientsunderwent nerve-sparing (NS) RRP at our institution; 45% unilateral orpartial-bilateral, and 55% bilateral nerve-sparing. Each patient wasattributed 0 or 4 points for the presence or absence of biochemicalprogression (PSA > 0.2 ng/ml), 0 or 2 points for the presence orabsence of urinary incontinence (any use of pads) and 0 or 1 point forthe presence or absence of impotence (no erections firm enough forpenetration). The sum of these points provides the Salomon-score.We compared the scores of our own institution to those published bySalomon et al.Results: The response rate was 71.7%. Patients reportingpreoperative ED or incontinence were excluded; leaving 176 patientsin the final analysis. Mean age was 59.45 years. At a minimum of 18months postoperatively, 41% of patients were potent, 87% of patientsreported no pad use. Seven patients experienced biochemicalprogression. Salomon-scores are shown in the table.Conclusion: This study is the first to evaluate the Salomon-score inreporting combined oncological and functional outcome after RRP. Itprovides an excellent way to present outcome of NS-RRP andfacilitates comparison of outcomes between various centres.143